No abstract available
MeSH terms
-
Antineoplastic Agents / administration & dosage*
-
Combined Modality Therapy
-
Cystadenocarcinoma / drug therapy*
-
Cystadenocarcinoma / pathology
-
Cystadenocarcinoma / secondary
-
Cystadenocarcinoma / surgery*
-
Humans
-
Infusions, Parenteral
-
Lymphatic Metastasis
-
Neoplasm Recurrence, Local
-
Palliative Care
-
Peritoneal Neoplasms / drug therapy*
-
Peritoneal Neoplasms / pathology
-
Peritoneal Neoplasms / surgery*
-
Reoperation